|
|
||||||||
Departments of Anesthesiology and of Physiology and Biophysics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905
| |
ABSTRACT |
|---|
|
|
|---|
Maximum velocity of the actomyosin
ATPase reaction (Vmax ATPase) and ATP
consumption rate during maximum isometric activation (ATPiso) were determined in human vastus lateralis (VL)
muscle fibers expressing different myosin heavy chain (MHC) isoforms. We hypothesized that the reserve capacity for ATP consumption [1
(ratio of ATPiso to Vmax
ATPase)] varies across VL muscle fibers expressing different MHC
isoforms. Biopsies were obtained from 12 subjects (10 men and 2 women;
age 21-66 yr). A quantitative histochemical procedure was used to
measure Vmax ATPase. In permeabilized fibers,
ATPiso was measured using an NADH-linked fluorometric procedure. The reserve capacity for ATP consumption was lower for
fibers coexpressing MHC2X and MHC2A compared
with fibers singularly expressing MHC2A and
MHCslow (39 vs. 52 and 56%, respectively). Tension cost
(ratio of ATPiso to generated force) also varied with fiber
type, being highest in fibers coexpressing MHC2X and MHC2A. We conclude that fiber-type differences in the
reserve capacity for ATP consumption and tension cost reflect
functional differences such as susceptibility to fatigue.
quantitative histochemistry; immunohistochemistry; muscle biopsy; sodium dodecyl sulfate-polyacrylamide electrophoresis; adenosine triphosphate
| |
INTRODUCTION |
|---|
|
|
|---|
MYOSIN HEAVY CHAIN (MHC) is the site of ATP hydrolysis during cross-bridge cycling, and ATP consumption rate during cross-bridge cycling is a major determinant of the mechanical performance of skeletal muscle fibers. This is evident by the close relationship between the maximum velocity of the actomyosin ATPase reaction (Vmax ATPase), measured biochemically, and the fiber-type composition and contractile properties of various skeletal muscles (3).
Several recent studies have used an NADH-linked fluorometric technique
to measure the rate of ATP consumption in single permeabilized muscle
fibers during maximum isometric activation (ATPiso)
(6, 22, 23, 25). In both animal (6, 22, 23)
and human (25) studies, muscle fibers expressing the
MHCslow isoform were found to have a slower rate
ATPiso compared with fibers expressing fast MHC isoforms
(MHC2A, MHC2X, and MHC2B). However,
ATPiso is submaximal, and therefore this measure does not
establish the maximum capacity for ATP hydrolysis (22,
23). It is well established that ATP consumption increases with
power output and work performance (11, 12, 22). The
Vmax ATPase establishes the upper limit for ATP
consumption during work performance for each fiber type in skeletal
muscle. In this respect, it is important to establish the range of ATP
consumption rates (from ATPiso to
Vmax ATPase) because this provides a measure of
the reserve capacity for ATP consumption. In the rat diaphragm muscle,
we found that the reserve capacity for ATP consumption [calculated as
1
(ratio of ATPiso to Vmax
ATPase)] was ~64, ~54, and ~52% for fibers expressing MHCslow, MHC2A, and MHC2X/2B,
respectively (23). Unfortunately, values obtained in
laboratory animals cannot be necessarily extrapolated to human muscle
fibers. Therefore, the purpose of the present study was to determine
the reserve capacity for ATP consumption of single permeabilized fibers
from the human vastus lateralis (VL) muscle. We hypothesized that the
reserve capacity for ATP consumption varies across VL muscle fibers
expressing different MHC isoforms.
| |
METHODS |
|---|
|
|
|---|
Muscle biopsies.
Needle-biopsy samples (~50-100 mg) were obtained from the
superficial portion of the VL muscle in 12 healthy but sedentary volunteers (10 men, 2 women; age 21-66 yr). Muscle samples used for measurement of ATPiso were cleaned of visible fat and
connective tissue and placed in a relaxing solution, at 5°C for
24 h, consisting of 85 mM K+, 1 mM free
Mg2+, 5 mM MgATP, 7 mM EGTA, propionate as the major anion,
and 10
9 M free Ca2+ [
log Ca2+
concentration (pCa) 9.0]; imidazole was used to maintain the pH at
7.0 ± 0.02 and to adjust the ionic strength to 150 mM. The fiber
bundles were then transferred to relaxing solution containing 50%
glycerol (vol/vol) and stored at
20°C for no more than 4 wk before
subsequent analysis.
80°C. No
attempt was made to stretch the muscle sample to optimal length before freezing.
Permeabilized single-fiber preparation. Glycerinated fiber bundles were transferred to a relaxing solution containing 10 mM dithiothreitol (DTT) and dissected under a microscope. The dissected single fibers were then transferred to a relaxing solution containing 10 mM DTT and 1% Triton X-100 for 20-30 min to permeabilize the plasma membrane. The permeabilized fibers were again transferred to 50% glycerol relaxing solution before measurements of ATPiso. Permeabilized single fibers, ~3 mm in length, were mounted between force and displacement transducers in a quartz cuvette that was perfused with solutions containing free ionized Ca2+ concentrations of either 1 nM (pCa 9.0) or 100 µM (pCa 4.0) maintained at 15°C. Muscle fiber length was adjusted so that average sarcomere length was 2.5 µm.
Measurement of maximum isometric force and ATPiso. Maximum isometric force (Fmax) and ATPiso were measured concurrently at 15°C in a Gûth Scientific Instruments Muscle Research System (16, 17, 20). The procedures for measuring isometric force in single permeabilized muscle fiber has been previously reported (14, 15, 20, 22, 23). In preliminary studies on human fibers, we confirmed that Fmax is obtained at pCa 4.0 and that no active force was obtained at pCa of 9.0.
The NADH-linked fluorometric technique for measuring ATPiso has been previously described in detail (16, 17, 20, 22, 23). Using this procedure, it was confirmed that mitochondrial ATPases and sarcoplasmic reticulum ATPase make no detectable contribution to the observed ATPase activity (17). Measurements of ATPiso were made while fibers were mounted in the quartz cuvette and perfused with either relaxing (pCa 9.0) or activating (pCa 4.0) solutions. NADH fluorescence was excited at 340 nm using a mercury lamp and an interposed band-pass filter. Emitted fluorescence was measured at 450 nm using a photomultiplier tube. The ATP solutions consisted of relaxing (pCa 9.0) and activating (pCa 4.0) solutions, both containing 5 mM phospho(enol)pyruvate (PEP), 0.2 mM NADH, 100 U/ml pyruvate kinase (PK), 140 U/ml lactate dehydrogenase (LDH), and 0.2 mM P1,P5- di(adenosine-5')pentaphosphate. The NADH-linked enzymatic assay involves the following reactions
|
(1) |
|
(2) |
|
(3) |
|
Gel electrophoretic determination of MHC isoform expression in single fibers. After completion of the force and ATPiso measurements, the MHC isoform composition of the muscle fiber was determined by SDS-PAGE using a previously described procedure (14, 15, 22, 23). Briefly, fibers were placed in 25 µl of SDS sample buffer containing 62.5 mM Tris · HCl, 2% (wt/vol) SDS, 10% (vol/vol) glycerol, and 0.001% (wt/vol) bromophenol blue at a pH of 6.8. The sample was denatured by boiling for 2 min, and 10-µl samples [~125 ng as determined by the Lowry method (19)] were loaded per lane. The gels were silver stained to visualize the MHC migration bands. Two mixed muscle fiber samples were run on each gel to compare the migration patterns of identified MHC isoforms. In the case of coexpression of MHC isoforms within a single fiber, the relative expression of each MHC isoform was determined by densitometric analysis.
Quantitative histochemical measurement of fiber
Vmax ATPase.
The quantitative histochemical procedure for measuring the
Vmax ATPase in type-identified muscle fibers has
been previously described in detail (4, 24). Serial cross
sections of muscle fibers were cut at 10-µm thickness using a
cryostat kept at
20°C, and alternate sections were used to
determine MHC isoform expression and the Vmax
ATPase. In four alternate transverse sections, immunoreactivity against
antibodies specific for anti-MHCslow (NCL),
anti-MHC2A (SC-71), and anti-MHCall-2X
(BF-35) (MHCall-2X means all but the MHC2X
isoform) was evaluated. Primary antibodies were diluted in PBS
(pH 7.4) containing 0.5% bovine serum albumin and were then applied to
the muscle sections for ~12 h at room temperature in a humidified
chamber. Slides were then washed in PBS and incubated with a
fluorescein-conjugated secondary antibody (goat anti-mouse IgG) for
~60 min at room temperature in a humidified chamber. The slides were
then washed in PBS, coverslipped with Permount, and viewed through a
microscope (model BH2, Olympus) equipped with epifluorescence. An
additional four alternate sections were stained for myofibrillar ATPase
(mATPase) after preincubation at pH 4.3, 4.6, 9.0, and 10.4 (after 4%
paraformaldehyde fixation) (7, 24).
|
Statistical analysis. Values are reported as means ± SE. A one-way ANOVA with repeated-measures design was used to independently assess fiber-type differences in histochemical Vmax ATPase and ATPiso. Post hoc analysis (Neuman-Keuls) was performed when appropriate. Statistical significance was accepted when P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Electrophoretic determination of MHC isoform
expression in single fibers.
The VL muscle displayed three distinct MHC migration bands. On the
basis of Western blot analysis, these MHC migration bands were
found to correspond with the expression of MHCslow,
MHC2A, and MHC2x isoforms. To evaluate MHC
isoform expression in single VL fibers, a larger number of fibers were
sampled in addition to those used in the mechanical and energetic
studies (see Classification of fiber types in muscle cross
sections). Among human VL fibers, MHCslow
(n = 64) and MHC2A isoforms
(n = 65) were found to be singularly expressed.
However, the MHC2X isoform was not found to be singularly
expressed and was coexpressed predominantly with the MHC2A
isoform (n = 24; Fig. 3).
Within fibers coexpressing MHC2X and MHC2A, the
relative expression of each isoform ranged from 20 to 80%, but the
mean relative expression was 54.8 ± 1.2% MHC2X and
45.2 ± 1.2% MHC2A. In these preliminary studies, it was determined that the fiber-type composition of the VL muscle could
not be characterized from a single biopsy. It was estimated that up to seven biopsies would be required, and such repeated biopsies
were not possible in these subjects. In addition, there was a
relatively low abundance of fibers expressing the MHC2X isoform in the biopsies that were obtained. Indeed, it was necessary to
obtain biopsies from 12 subjects to obtain a sufficient sample of
fibers expressing the MHC2X isoform. For these reasons, it was not possible to characterize the overall population of this or
other fiber types in the VL of subjects. This raised the important issue of whether across-subject variability may have influenced the
results. For fibers expressing the MHC2X isoform, this
issue could not be addressed. However, in comparing values for fibers expressing MHCslow and MHC2A isoforms, there
were no significant differences across subjects. The coefficient of
variation for ATPiso of fibers expressing MHC2A
across subjects was 6.26%.
|
Classification of fiber types in muscle cross sections. The patterns of immunoreactivity against specific MHC antibodies in the VL muscle generally corresponded with the histochemical classification of fiber types. VL fibers classified histochemically as type I displayed immunoreactivity for the anti-MHCslow antibody, and fibers classified histochemically as type IIa displayed immunoreactivity for the anti-MHC2A antibody. However, the anti-MHCsll-2X antibody (BF-35), specific for all MHC isoforms except for MHC2X, was less reactive with fibers classified histochemically as type IIb, indicating expression of the MHC2X isoform. In these fibers, immunoreactivity for the MHCall-2X antibody varied from faint to moderate, and most of these fibers were also immunoreactive for the anti-MHC2A antibody in varying degrees. Therefore, these immunohistochemical results were consistent with the coexpression of MHC2A and MHC2X.
Fmax (n = 46).
Fmax of human VL fibers was significantly lower for fibers
expressing MHC2A (n = 21; range 10-20
N/cm2) compared with fibers expressing MHCslow
(n = 19; range 12-22 N/cm2; Table
1; P < 0.05). For fibers
coexpressing MHC2X and MHC2A (n = 6), there was a considerable range in Fmax (11-27
N/cm2). Unfortunately, there were an insufficient number of
fibers sampled in this group to determine whether Fmax
depended on the relative expression of MHC2X and
MHC2A.
|
ATPiso (n = 46).
The ATPiso of human VL fibers expressing the
MHCslow isoform was significantly lower than that of fibers
expressing MHC2A as well as fibers coexpressing the
MHC2X and MHC2A (P < 0.05; Fig. 4). The ATPiso of single
fibers singularly expressing MHC2A was also significantly
lower than that of fibers coexpressing MHC2X and
MHC2A (P < 0.05; Fig. 4).
|
Vmax ATPase (n = 525). The Vmax ATPase of VL muscle fibers expressing MHCslow was significantly lower than that of fibers expressing MHC2A either alone or coexpressed with MHC2X (P < 0.05; Fig. 4). The Vmax ATPase of fibers expressing MHC2A alone was significantly lower than that of fibers coexpressing MHC2X and MHC2A (P < 0.05; Fig. 4).
Reserve capacity of ATP consumption.
For human VL muscle fibers, the reserve capacity for ATP consumption
was calculated as
|
Isometric tension cost (n = 46).
For a measurement of ATP cost for generating force, the isometric
tension cost of human VL fibers was determined by dividing the
ATPiso by the corresponding isometric force. The tension
cost of human VL fibers expressing the MHCslow
isoform was significantly lower than that of fibers expressing
MHC2A (P < 0.05; Fig.
5). There were an insufficient number of
fibers sampled in this group to determine whether tension cost depended
on the relative expression of MHC2X and MHC2A.
Comparison of tension cost determined at 15°C between human VL fibers
and rat diaphragm fibers in our laboratory's previous study
(22) is shown in Fig. 5. The relationship between Vmax ATPase and tension cost is displayed in
Fig. 6.
|
|
Temperature dependence of ATPiso (n = 6).
The dependence of ATPiso was determined by comparing
measurements at 15, 20, and 25°C. As temperature increased,
ATPiso of fibers also increased. The Q10 value
of the ATPiso was 1.72 ± 0.16 (Fig.
7).
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study examined both maximal (Vmax ATPase) and submaximal (ATPiso) values for ATP consumption in human VL muscle fibers. The Vmax ATPase establishes the upper limit for ATP consumption during work performance for each fiber type in skeletal muscle (23). In this respect, it is important to determine the range of ATP consumption rates (from Vmax ATPase to ATPiso), because this provides a measure of the reserve capacity for ATP consumption. The present study reports important new information in this regard. The reserve capacity for ATP consumption was lower for fibers expressing MHC2X (coexpressed with MHC2A) compared with fibers expressing MHC2A and MHCslow. This is consistent with the lower energy efficiency of fibers expressing the MHC2X isoform as reflected by the higher tension cost of these fibers.
Similar to previous reports (10, 30), we found that three MHC isoforms were expressed in the VL muscle of healthy adult humans, MHCslow, MHC2A, and MHC2X. Other studies evaluating MHC isoform expression in the human VL muscle also found three isoforms, although MHC2B expression was reported rather than MHC2X (18, 25). Because there is now strong evidence to indicate that MHC2B is not expressed in human fibers, it is likely that expression of MHC2B was confused with MHC2X expression. On the basis of single-fiber gel electrophoresis and Western blot analysis, it appears that MHCslow and MHC2A are singularly expressed in VL fibers, whereas the MHC2X isoform is only coexpressed, predominantly with MHC2A. The coexpression of MHC2X and MHC2A in human VL muscle fibers has also been reported in other studies (10, 30). The pattern of MHC isoform expression in single human VL muscle fibers, as determined by SDS-PAGE, generally corresponded with the pattern of immunoreactivity against specific MHC antibodies, as well as the histochemical classification of fiber types based on the pH lability of myofibrillar mATPase staining. These results are consistent with other studies showing a relationship between histochemical fiber-type classification and MHC isoform composition in human muscle fibers (1, 10, 30).
Similar to the previous results of Stienen and colleagues (25) for the human rectus abdominis and VL muscles, we found that ATPiso varied across fibers expressing different MHC isoforms in human VL muscle. These results are also in general agreement with our laboratory's previous observations in the rat diaphragm muscle (22, 23). However, the values for ATPiso in human muscle fibers reported by Stienen and colleagues were lower than those found in the present study. These investigators measured ATPiso at 20°C rather than 15°C. The dependence of ATPiso on temperature was measured in both studies; a Q10 of 1.72 was found in the present study vs. a Q10 of 2.34 in the study of Stienen et al. Even when corrected for differences in temperature, the ATPiso values found in the present study were ~30-40% higher than those reported by Stienen et al. It should be noted that Stienen and colleagues measured NADH concentration by absorbency rather than fluorometry, and these technical differences may have accounted for the discrepancies in reported values.
31P-nuclear magnetic resonance (NMR) spectroscopy has
also been used to measure ATP consumption in human muscle fibers in
vivo on the basis of the dynamics of creatine phosphate content. Using this procedure, Blei and colleagues (5) reported an
average ATP consumption rate of 0.15 ± 0.03 nmol · mm
3 · s
1 during
single-twitch stimulation in the human forearm flexor musculature,
whereas Turner and colleagues (27) reported an average
value of 4.4 ± 0.4 nmol · mm
3 · s
1 in the
human adductor pollicis muscle during maximum isometric activation.
After corrections for the higher in vivo temperature were made, the
ATPiso for VL muscle fibers in the present study would
range from 1.02 ± 0.07 nmol · mm
3 · s
1 for fibers
expressing MHCslow to 3.06 ± 0.15 nmol · mm
3 · s
1 for fibers
coexpressing MHC2X and MHC2A. Using the
NADH-linked fluorometric procedure, only the ATP consumption related to
the actomyosin ATPase was measured, whereas in the 31P-NMR
spectroscopy method the total ATP consumption of activated fibers was
measured, including other membrane ATPases. These differences may
account for the slightly higher ATP consumption measured using 31P-NMR spectroscopy, although several other factors may
have also contributed.
In the present study, Vmax ATPase was highest for fibers coexpressing MHC2X and MHC2A and lowest for fibers expressing MHCslow. These results are consistent with the previous study of Castro et al. (8) on human VL muscle fibers using an identical technique. These results are also generally consistent with differences in the Vmax ATPase of fibers expressing different MHC isoforms in the rat diaphragm muscle (23).
The reserve capacity for ATP consumption in single muscle fibers was
estimated by the following calculation: 1
[ratio of the
ATPiso to the Vmax ATPase]. In a
previous study in the rat diaphragm muscle, our laboratory found that
the reserve capacity for ATP consumption ranged from ~64% for fibers
expressing MHCslow to ~52% for fibers
expressing fast MHC isoforms (23). In the human VL, we
found that fibers singularly expressing MHCslow and MHC2A had a greater reserve capacity (56 and 52%,
respectively) compared with fibers coexpressing MHC2X and
MHC2A (39%). It should be noted that both the
ATPiso and the Vmax ATPase for human
VL fibers were substantially lower than values for fibers expressing the same MHC isoforms (MHCslow, MHC2A, and
MHC2X) in the rat (22-24). Together,
these results indicate that ATPiso represents only
submaximal energy utilization compared with the
Vmax ATPase in muscle fibers. The
Vmax ATPase in a muscle fiber is
determined by the product of the ATP consumed per MHC molecule (i.e.,
the quantal contribution from a single myosin cross bridge) times the
number of available cross bridges (i.e., MHC concentration). Similarly,
ATPiso is determined by the ATP consumed per MHC molecule
times the number of cross bridges in the force-generating state. In
both cases, MHC concentration becomes an important determinant of ATP
consumption. Recently, our laboratory reported that, in the rat
diaphragm muscle, fibers expressing MHCslow and
MHC2A have lower MHC concentrations compared with fibers
expressing MHC2X and MHC2B (14).
Furthermore, our laboratory found that, during maximum isometric
activation, the fraction of cross bridges in the force-generating state
was comparable across fiber types (14). Thus, with a lower
MHC concentration, lower ATPiso and
Vmax ATPase would be expected for fibers
expressing MHCslow and MHC2A. However, when we
normalized our Vmax ATPase for
previously reported myofibrillar volume densities in the VL muscle
(28), fiber-type differences in ATPiso and
Vmax ATPase persisted. Thus it is likely that
the lower ATPiso and Vmax ATPase values seen in VL fibers expressing the MHCslow isoform
primarily reflect phenotypic differences in the capacity for ATP
consumption of MHCslow vs. MHC2A or
MHC2X molecules. The lower ATPiso and Vmax ATPase of fibers expressing
MHCslow are also likely to be reflected by a slower maximum
rate constant for cross-bridge detachment compared with fibers
expressing MHC2A or MHC2X (23).
It is not surprising that the ATPiso of muscle fibers was only a fraction of the Vmax ATPase (i.e., maximum capacity for ATP consumption). In 1923, Fenn observed that energy utilization of skeletal muscle increases in proportion to work (Fenn effect; Refs. 11, 12). Thus, as muscle fibers reach maximum power during shortening, ATP consumption rate should increase (22). In a previous study on the rat diaphragm muscle, our laboratory found that the maximum rate of ATP consumption was achieved at a shortening velocity corresponding to peak power output of fibers (22). Although the maximum rate of ATP consumption achieved at peak power output was closer to the Vmax ATPase, it was still less. This may reflect differences in the number of cross bridges contributing to the measured ATP consumption rate during active shortening vs. those contributing to the measurements of Vmax ATPase.
The Fmax values for human VL muscle fibers measured in the present study were comparable to those reported in previous studies in single fibers (9, 18, 25, 29) as well as whole human muscle in vivo (13). We found that the Fmax of VL fibers expressing MHCslow was slightly greater than that for fibers expressing MHC2A. In contrast, Stienen et al. (25) reported that VL fibers expressing MHCslow generated lower Fmax compared with fibers expressing fast MHC isoforms. Larsson and Moss (18) reported no significant differences in Fmax across human VL muscle fibers expressing different MHC isoforms. In the rat diaphragm muscle, our laboratory found that fibers expressing MHCslow generated lower Fmax compared with fibers expressing fast MHC isoforms (14, 15, 22, 23).
The tension cost (the ratio of ATPiso to isometric force; Fig. 5) of human VL muscle fibers reported in the present study is in general agreement with that reported by Steinen et al. (25). Fibers expressing MHCslow had the lowest values of tension cost followed by fibers expressing MHC2A and fibers coexpressing MHC2X and MHC2A. Therefore, fibers expressing MHCslow are the most energy efficient. Compared with values of tension cost reported for rat diaphragm muscle fibers (22), the tension cost of human VL muscle fibers was significantly lower. These results generally agree with the principle that energetic costs of generating muscular force are lower in larger animals (26).
In conclusion, measurement of submaximal and maximal rates of ATP consumption in the present study indicates that a substantial reserve capacity for ATP consumption exists in human muscle fibers. In addition, fiber-type differences in the reserve capacity for ATP consumption exist, with fibers expressing MHC2X (coexpressed with MHC2A) displaying a significantly lower reserve capacity compared with fibers singularly expressing MHC2A and MHCslow. These measurements provide new information that is important in determining the balance between energy supply and demand. Certainly this reserve capacity for ATP consumption becomes important under conditions where ATP production may be insufficient to meet the demands for cross-bridge cycling. Such an energetic imbalance has been suggested as an underlying mechanism of muscle fatigue. The lower reserve capacity for ATP consumption, together with the higher ATP consumption rates, may explain, at least in part, the greater fatigue susceptibility of fibers expressing MHC2X (21). Under conditions of greater workloads, as energy utilization increases in proportion to work (Fenn effect; Refs. 11, 12), reserve capacity for ATP consumption decreases and susceptibility to fatigue increases (2). Therefore, these novel results regarding the reserve capacity of ATP consumption in human VL muscle fibers have important functional implications.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Janet L. Vittone, Y. H. Fang, Heidi M. Hinderaker, A. Iyanoye, Rebecca Macken, and J. Sieck for their assistance in these studies.
| |
FOOTNOTES |
|---|
This research was supported by National Heart, Lung, and Blood Institute Grants HL-34817 and HL-37680.
Address for reprint requests and other correspondence: G. C. Sieck, Anesthesia Research, Mayo Clinic and Foundation, 200 First St. SW, Rochester, MN 55905 (E-mail: sieck.gary{at}mayo.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 9 June 2000; accepted in final form 31 August 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adams, GR,
Hather BM,
Baldwin KM,
and
Dudley GA.
Skeletal muscle myosin heavy chain composition and resistance training.
J Appl Physiol
74:
911-915,
1993
2.
Ameredes, BT,
Zhan WZ,
Vanderboom R,
Prakash YS,
and
Sieck GC.
Power fatigue of the rat diaphragm muscle.
J Appl Physiol
89:
2215-2219,
2000
3.
Barany, M.
ATPase activity of myosin correlated with speed of muscle shortening.
J Gen Physiol
50:
197-216,
1967
4.
Blanco, CE,
and
Sieck GC.
Quantitative determination of calcium-activated myosin adenosine triphosphatase activity in rat skeletal muscle fibres.
Histochem J
24:
431-444,
1992[ISI][Medline].
5.
Blei, ML,
Conley KE,
and
Kushmerick MJ.
Separate measures of ATP utilization and recovery in human skeletal muscle.
J Physiol
465:
203-222,
1993
6.
Bottinelli, R,
Canepari M,
Reggiani C,
and
Stienen GJM
Myofibrillar ATPase activity during isometric contraction and isomyosin composition in rat single skinned muscle fibres.
J Physiol (Lond)
481:
663-675,
1994[ISI][Medline].
7.
Brooke, MH,
and
Kaiser KK.
Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence.
J Histochem Cytochem
18:
670-672,
1970[ISI][Medline].
8.
Castro, MJ,
Apple DFJ,
Melton-Rogers S,
and
Dudley GA.
Muscle fiber type-specific myofibrillar Ca(2+) ATPase activity after spinal cord injury.
Muscle Nerve
23:
119-121,
2000[ISI][Medline].
9.
Eddinger, TJ,
Gassens RG,
and
Moss RL.
Mechanical and histochemical characterization of skeletal muscles from senescent rats.
Am J Physiol Cell Physiol
251:
C421-C430,
1986
10.
Ennion, S,
Sant'Ana Pereira J,
Sargeant AJ,
Young A,
and
Goldspink G.
Characterization of human skeletal muscle fibres according to the myosin heavy chains they express.
J Muscle Res Cell Motil
16:
35-43,
1995[ISI][Medline].
11.
Fenn, WO.
A quantitative comparison between the energy liberated and the work performed by the isolated sartorius muscle of the frog.
J Physiol (Lond)
58:
175-203,
1923.
12.
Fenn, WO.
The relation between the work performed and the energy liberated in muscular contraction.
J Physiol (Lond)
58:
373-395,
1924.
13.
Fukunaga, T,
Roy RR,
Shellock FG,
Hodgson JA,
and
Edgerton VR.
Specific tension of human plantar flexors and dorsiflexors.
J Appl Physiol
80:
158-165,
1996
14.
Geiger, PC,
Cody MJ,
Macken RL,
and
Sieck GC.
Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers.
J Appl Physiol
89:
695-703,
2000
15.
Geiger, PC,
Cody MJ,
and
Sieck GC.
Force-calcium relationship depends on myosin heavy chain and troponin isoforms in rat diaphragm muscle fibers.
J Appl Physiol
87:
1894-1900,
1999
16.
Guth, K,
and
Wojciechowski R.
Instruments and techniques: perfusion cuvette for the simultaneous measurement of mechanical, optical and energetic parameters of skinned muscle fibres.
Pflügers Arch
407:
552-557,
1986[ISI][Medline].
17.
Kerrick, WG,
Potter JD,
and
Hoar PE.
The apparent rate constant for the dissociation of force generating myosin cross-bridges from actin decreases during Ca2+ activation of skinned muscle fibres.
J Muscle Res Cell Motil
12:
53-60,
1991[ISI][Medline].
18.
Larsson, L,
and
Moss RL.
Maximum velocity of shortening in relation to myosin isoform composition in single fibers from human skeletal muscles.
J Physiol
472:
595-614,
1993
19.
Lowry, OH,
Rosenbrough NJ,
Farr AL,
and
Randall RJ.
Protein measurement with the Folin phenol reagent.
J Biol Chem
193:
265-275,
1951
20.
Perkins, WJ,
Han YS,
and
Sieck GC.
Skeletal muscle force and actomyosin ATPase activity reduced by nitric oxide donor.
J Appl Physiol
83:
1326-1332,
1997
21.
Sieck, GC,
and
Fournier M.
Diaphragm motor unit recruitment during ventilatory and nonventilatory behaviors.
J Appl Physiol
66:
2539-2545,
1989
22.
Sieck, GC,
Han YS,
Prakash YS,
and
Jones KA.
Cross-bridge cycling kinetics, actomyosin ATPase activity and myosin heavy chain isoforms in skeletal and smooth respiratory muscles.
Comp Biochem Physiol B Biochem Mol Biol
119:
435-450,
1998[Medline].
23.
Sieck, GC,
and
Prakash YS.
Cross bridge kinetics in respiratory muscles.
Eur Respir J
10:
2147-2158,
1997[Abstract].
24.
Sieck, GC,
Zhan WZ,
Prakash YS,
Daood MJ,
and
Watchko JF.
SDH and actomyosin ATPase activities of different fiber types in rat diaphragm muscle.
J Appl Physiol
79:
1629-1639,
1995
25.
Stienen, GJM,
Kiers JG,
Bottinelli R,
and
Reggiani C.
Myofibrillar ATPase activity in skinned human skeletal muscle fibres: fibre type and temperature dependence.
J Physiol (Lond)
493:
299-309,
1996[ISI][Medline].
26.
Taylor, CR,
Heglund NC,
McMahon TA,
and
Looney TR.
The energetic cost of generating muscular force during running.
J Exp Biol
86:
9-18,
1980
27.
Turner, DL,
Jones DA,
McIntyre DB,
and
Newham DJ.
ATP turnover measured by 31P-magnetic resonance spectroscopy in human adductor pollicis during isometric and shortening contractions (Abstract).
J Physiol
459:
154P,
1993.
28.
Wang, N,
Hikida R,
Staron R,
and
Simoneau J.
Muscle fiber types of women after resistance training
quantitative ultrastructure and enzyme activity.
Pflügers Arch
424:
494-502,
1993[ISI][Medline].
29.
Wood DS, Zollman J, and Reuben JP. Human skeletal muscle:
properties of the "chemically skinned" fiber.
Science: 1075-1076, 1974.
30.
Zhou, MY,
Klitgaard H,
Saltin B,
Roy RR,
Edgerton VR,
and
Gollnick PD.
Myosin heavy chain isoforms of human muscle after short-term spaceflight.
J Appl Physiol
78:
1740-1744,
1995
This article has been cited by other articles:
![]() |
G. C. Sieck, W.-Z. Zhan, Y.-S. Han, and Y. S. Prakash Effect of denervation on ATP consumption rate of diaphragm muscle fibers J Appl Physiol, September 1, 2007; 103(3): 858 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Howlett and M. C. Hogan Muscle: Effect of hypoxia on fatigue development in rat muscle composed of different fibre types Exp Physiol, September 1, 2007; 92(5): 887 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qian, L. W. Hunter, H. Du, Q. Ren, Y. Han, and G. C. Sieck Pkd2+/- Vascular Smooth Muscles Develop Exaggerated Vasocontraction in Response to Phenylephrine Stimulation J. Am. Soc. Nephrol., February 1, 2007; 18(2): 485 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szentesi, M. A. Bekedam, B. J. van Beek-Harmsen, W. J. van der Laarse, R. Zaremba, A. Boonstra, F. C. Visser, and G. J. M. Stienen Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure J Appl Physiol, December 1, 2005; 99(6): 2189 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. C. Ottenheijm, L. M. A. Heunks, G. C. Sieck, W.-Z. Zhan, S. M. Jansen, H. Degens, T. de Boo, and P. N. R. Dekhuijzen Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Short, J. L. Vittone, M. L. Bigelow, D. N. Proctor, J. M. Coenen-Schimke, P. Rys, and K. S. Nair Changes in myosin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training J Appl Physiol, July 1, 2005; 99(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M Gregory and C S. Bickel Recruitment Patterns in Human Skeletal Muscle During Electrical Stimulation Physical Therapy, April 1, 2005; 85(4): 358 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levine, T. Nguyen, L. R. Kaiser, N. A. Rubinstein, G. Maislin, C. Gregory, L. C. Rome, G. A. Dudley, G. C. Sieck, and J. B. Shrager Human Diaphragm Remodeling Associated with Chronic Obstructive Pulmonary Disease: Clinical Implications Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 706 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Han, P. C. Geiger, M. J. Cody, R. L. Macken, and G. C. Sieck ATP consumption rate per cross bridge depends on myosin heavy chain isoform J Appl Physiol, June 1, 2003; 94(6): 2188 - 2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sieck, Y. S. Prakash, Y.-S. Han, Y.-H. Fang, P. C. Geiger, and W.-Z. Zhan Changes in actomyosin ATP consumption rate in rat diaphragm muscle fibers during postnatal development J Appl Physiol, May 1, 2003; 94(5): 1896 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
C S. Bickel, J. M Slade, G. L Warren, and G. A Dudley Fatigability and Variable-Frequency Train Stimulation of Human Skeletal Muscles Physical Therapy, April 1, 2003; 83(4): 366 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levine, C. Gregory, T. Nguyen, J. Shrager, L. Kaiser, N. Rubinstein, and G. Dudley Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD J Appl Physiol, March 1, 2002; 92(3): 1205 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Talmadge, M. J. Castro, D. F. Apple Jr., and G. A. Dudley Phenotypic adaptations in human muscle fibers 6 and 24 wk after spinal cord injury J Appl Physiol, January 1, 2002; 92(1): 147 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Proctor, J. D. Miller, N. M. Dietz, C. T. Minson, and M. J. Joyner Reduced submaximal leg blood flow after high-intensity aerobic training J Appl Physiol, December 1, 2001; 91(6): 2619 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perrey, A. Betik, R. Candau, J. D. Rouillon, and R. L. Hughson Comparison of oxygen uptake kinetics during concentric and eccentric cycle exercise J Appl Physiol, November 1, 2001; 91(5): 2135 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sieck and M. Regnier Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Plasticity and energetic demands of contraction in skeletal and cardiac muscle J Appl Physiol, March 1, 2001; 90(3): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
| |||||